WebDisclosure WebDisclosure
Basculer en Français
9732 Companies
194355 Keywords
125495 Articles
103395 Press releases
Headlines Articles Press releases Viatris Inc. Remove
  1. Home
  2. Companies
  3. Viatris Inc.
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 11/19/2025 at 09:10, 2 months 5 days ago

    European Study Highlights Declining Antibiotic Prices Amid Rising Costs and Shortages

    Production Costs Policy Reform Antibiotic Prices Shortages Healthcare Impact
  • BRIEF

    published on 11/19/2025 at 09:10, 2 months 5 days ago

    Une étude européenne met en lumière la baisse des prix des antibiotiques malgré la hausse des coûts et les pénuries.

    Coûts De Production Réforme Des Politiques Prix Des Antibiotiques Pénuries Impact Sur Les Soins De Santé
  • PRESS RELEASE

    published on 11/19/2025 at 09:05, 2 months 5 days ago

    European study shows falling prices, rising costs and shortages - findings from independent study presented during World AMR Awareness Week by Viatris and Medicines for Europe

    European study by Viatris and Medicines for Europe reveals falling prices, rising costs, and shortages in off-patent antibiotics, underscoring the urgency of coordinated action against antimicrobial resistance
    Healthcare Antibiotics Viatris Medicines For Europe AMR Awareness Week
    Logo of Viatris Inc.
Accesswire
  • Published on 01/24/2026 at 01:00, 12 hours 11 minutes ago

    Pegasus Resources Executes Other Business Arrangement (OBA) for 640 Acres of Uranium Exploration Lands in Utah

  • Published on 01/24/2026 at 01:00, 12 hours 11 minutes ago

    Onco-Innovations Announces Private Placement

  • Published on 01/23/2026 at 23:30, 13 hours 41 minutes ago

    CORRECTION FROM SOURCE: IBC Announces Incentive Stock Option Awards

  • Published on 01/23/2026 at 23:20, 13 hours 51 minutes ago

    Silver Tiger Announces Filing of a PEA for the Underground and an Updated Pre-Feasibility Study Technical Report for the El Tigre Silver-Gold Project

  • Published on 01/23/2026 at 23:10, 14 hours 1 minute ago

    Early Warning Press Release – Acquisitions by Pierre Lassonde in Fuerte Metals

View all ACCESSWIRE
EQS Group
  • Published on 01/23/2026 at 21:21, 15 hours 50 minutes ago

    EQS-Adhoc: LR Health & Beauty SE: PRELIMINARY RESULTS FOR FINANCIAL YEAR 2025 / TARGETED EQUITY CONTRIBUTION / TARGETED RESTRUCTURING OF THE 2024/2028 BONDS

  • Published on 01/23/2026 at 20:00, 17 hours 11 minutes ago

    EUROPLASMA: Europlasma fait un point sur la situation de Fonderie de Bretagne

  • Published on 01/23/2026 at 19:42, 17 hours 29 minutes ago

    EQS-Adhoc: ABO Energy GmbH & Co. KGaA concludes standstill agreement with creditors of significant financing arrangements

  • Published on 01/23/2026 at 19:02, 18 hours 9 minutes ago

    Fuller, Smith & Turner PLC: Transaction in own shares

  • Published on 01/23/2026 at 18:50, 18 hours 21 minutes ago

    Mercedes-AMG PETRONAS F1 Team Announces Collaboration Agreement with Zuma

View all EQS
Les Echos
  • Published on 01/23/2026 at 18:00, 19 hours 11 minutes ago

    i2S : Chiffre d'affaires 2025

  • Published on 01/23/2026 at 17:26, 19 hours 45 minutes ago

    ENGIE- Mise à disposition des documents préparatoires AGM 24.04.2025

  • Published on 01/22/2026 at 18:00, 1 day 19 hours ago

    TERACT - Independent expert appointment

  • Published on 01/22/2026 at 18:00, 1 day 19 hours ago

    TERACT - Nomination de l’expert indépendant

  • Published on 01/22/2026 at 18:00, 1 day 19 hours ago

    2025 revenue

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy